Legal & General Group
CALA

Legal & General Group’s Calithera Biosciences, Inc CALA Stock Holding History

Legal & General Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-486
Closed -$24K – 3734
2021
Q1 		$24K Sell
486
-14
-3% -$815 ﹤0.01% 3067
2020
Q4 		$49K Hold
500
– – ﹤0.01% 2810
2020
Q3 		$34K Sell
500
-145
-22% -$12.7K ﹤0.01% 2810
2020
Q2 		$68K Buy
645
+286
+80% +$34K ﹤0.01% 2638
2020
Q1 		$32K Sell
359
-45
-11% -$5.36K ﹤0.01% 2744
2019
Q4 		$46K Buy
404
+13
+3% +$978 ﹤0.01% 2847
2019
Q3 		$24K Buy
391
+116
+42% +$9.29K ﹤0.01% 3079
2019
Q2 		$21K Hold
275
– – ﹤0.01% 3185
2019
Q1 		$37K Hold
275
– – ﹤0.01% 2837
2018
Q4 		$22K Buy
275
+75
+38% +$7.4K ﹤0.01% 3048
2018
Q3 		$21K Hold
200
– – ﹤0.01% 3191
2018
Q2 		$20K Sell
200
-72
-26% -$8.16K ﹤0.01% 3194
2018
Q1 		$34K Sell
272
-110
-29% -$17.2K ﹤0.01% 2932
2017
Q4 		$64K Sell
382
-20
-5% -$5.12K ﹤0.01% 2777
2017
Q3 		$126K Sell
402
-3
-0.7% -$946 ﹤0.01% 2520
2017
Q2 		$120K Buy
+405
New +$108K ﹤0.01% 2508

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's CALA Position: Q2 2021 in Review

Legal & General Group sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 486 shares — an estimated $24K sold.

Legal & General Group first reported a position in CALA in Q2 2017 and held it in 16 quarters. The position peaked at $126K in Q3 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Legal & General Group reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 486 Calithera Biosciences, Inc shares in Q2 2021, an estimated $24K.
  • Legal & General Group first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 16 quarters.
  • Legal & General Group's Calithera Biosciences, Inc position peaked at $126K in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.